Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from FDA

Federal judge at center of FDA abortion drug case has history with conservative causes

U.S. District Matthew Kacsmaryk was once deputy counsel for the First Liberty Institute, the Plano-based conservative Christian law firm.

The Texas Tribune

Trump-appointed judge hears from anti-abortion groups and Justice Department in high-stakes abortion drug case

The federal judge overseeing the biggest abortion case since the Supreme Court overturned Roe v Wade could block access to a commonly used abortion drug

The Independent UK

3 Colossal Stocks to Buy Hand Over Fist Right Now

High-profile bank failures and stubbornly high inflation have heightened volatility in the stock market lately. Regardless of uncertain macroeconomic conditions, colossal stocks Visa (V), Merck (MRK), and Salesforce (CRM) could be ideal buys for market-beating returns. Continue reading….

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

When will Medicare cover medical marijuana?

Many older adults are using medical marijuana to treat a variety of conditions, but experts say that conflicting laws, unclear safety standards and complicated rulemaking processes mean it could be years before Medicare may cover the drug

The Independent UK

Access to abortion pill in the balance as Texas judge hears mifepristone case

Trump-appointed judge says he will rule ‘as soon as possible’ on case brought by far-right anti-abortion groups

The Guardian - US

Is Internet Spoonie Culture Keeping People Sick?

While the FDA keeps experimental treatments out of reach, the spoonie world makes a diagnosis into an identity.

Reason

Abortion pill challenge goes before judge in Texas

A federal judge will hear arguments in a high-stakes court case that could threaten access to medication abortion and blunt the authority of U.S. drug regulators

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

They lost weight on Wegovy—the same drug as Ozempic. Here's what happened when they stopped taking it

Experts say these should be considered long-term medications.

Fortune

Short on Adderall? Blame DEA Production Caps

Each year, the DEA sets production limits for certain drugs, including some ingredients in common amphetamine pills like Adderall.

Reason

Judge tried hiding abortion pill hearing

Matthew Kacsmaryk's actions ahead of a hearing planned for Wednesday were "bordering on judicial misconduct"

Salon

Democratic attorneys general sue Biden administration over FDA abortion pill regulation

A group of 12 Democratic state attorneys general filed a lawsuit in the United States District Court for the Eastern District of Washington against the Food and Drug Administration (FDA) on Feb. 23, 2023, arguing that the agency’s regulations on the abortion-inducing drug mifepristone violate state sovereignty by limiting the…

Ballotpedia

Why fake sugars may be bad for you

Erythritol, a popular alternative to sugar, may increase risk of stroke. Is any fake sugar safe?

Salon

FDA approves world’s first fast-acting nasal spray to treat migraines

Drug marks ‘significant breakthrough’ for people with migraine who need freedom from pain

The Independent UK

Trump-appointed judge limits information on medication abortion lawsuit

The suit could determine whether US women can access abortion drugs, but judge is trying to limit disruptions and protests

The Guardian - US

Get all your
news in one place.

100's of premium titles.
One news app.

Tribune News Service

Texas abortion ruling nears, but blue states aren't waiting to protect pill access

A federal judge in Texas soon could make one of the two pills used in medication abortions harder to come by, even in blue states that support abortion rights.

Tribune News Service

Pfizer receives FDA approval for migraine nasal spray, claims pain relief in 15 minutes

The U.S. Food and Drug Administration has approved a nasal spray developed by Pfizer as a means to quickly treat the painful symptoms associated with suffering a migraine.

The Independent UK

Juul to pay Chicago $23.8M for underage vaping settlement

E-cigarette company Juul Labs will pay Chicago $23.8 million to settle a lawsuit alleging the company marketed harmful vaping products to underage users, the city announced Friday

Fortune

Pedro Pascal’s apparently caffeine-laden Starbucks order is sending TikTok into a frenzy. But is it safe?

Each Starbucks espresso shot contains 75 milligrams of caffeine. Six shots would total 450 milligrams of caffeine—just slightly over the U.S. Food and Drug Administration’s recommended daily limit of 400 milligrams.

Get all your
news in one place.

100's of premium titles.
One news app.

Salon

The rise of lab-grown meat

We may soon enter a new era of "meat" . . . but what exactly does this mean?

Salon

Walgreens hit with abortion backlash

The hashtag #boycottwalgreens has been growing on Twitter and TikTok

StockNews.com

2 Stocks That'll Help You Keep Money in Your Pockets

Rising anxieties owing to the likelihood of an impending recession have weighed heavily on the stock market. Given the uncertainties are not likely to ease anytime soon, quality stocks Johnson & Johnson (JNJ) and Pfizer (PFE) might be wise portfolio additions to help you keep money in your pockets. Read…

The Guardian - UK

Home Office officials demand apology from Suella Braverman over ‘attack on integrity’

Email in name of home secretary claimed civil servants had blocked attempts to curb migration

Salon

Sanders: "Medicare for All" must wait

As new chairman of the Senate HELP Committee, Sanders maps out his strategy for negotiating with GOP and Big Pharma

Fortune

Abortion pill Mifepristone got Walgreens into hot water

Two parallel storylines related to the pill are capturing headlines.

Axios

Growth of AI in mental health raises fears of its ability to run wild

The rise of AI in mental health care has providers and researchers increasingly concerned over whether glitchy algorithms, privacy gaps and other perils could outweigh the technology's promise and lead to dangerous patient outcomes.

1 … 156 157 158 159

People

Sristi Suman JayaswalThe

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.